000065586 001__ 65586
000065586 005__ 20190709135640.0
000065586 0247_ $$2doi$$a10.3389/fpsyt.2017.00307
000065586 0248_ $$2sideral$$a104181
000065586 037__ $$aART-2018-104181
000065586 041__ $$aeng
000065586 100__ $$aMontero-Marín, J.
000065586 245__ $$aEfficacy of "attachment-based compassion therapy" in the treatment of fibromyalgia: A randomized controlled trial
000065586 260__ $$c2018
000065586 5060_ $$aAccess copy available to the general public$$fUnrestricted
000065586 5203_ $$aObjective: There is a growing interest in evaluating the effectiveness of compassion interventions for treating psychological disorders. The present study evaluated the effectiveness of "attachment-based compassion therapy" (ABCT) in the treatment of fibromyalgia (FM), and the role of psychological flexibility as a mediator of improvements. Methods: A total of 42 patients with FM were randomly assigned to ABCT or relaxation (active control group). Both the intervention and control condition were combined with treatment as usual (TAU). The primary outcome was functional status (FIQ), and the secondary outcomes were clinical severity (CGI-S), pain catastrophizing (PCS), anxiety (HADS-A), depression (HADS-D), quality of life (EQ-5D), and psychological flexibility (AAQ-II). Differences between the groups were estimated using mixed-effects models, and mediation assessments were conducted using path analyses. Results: The ABCT group demonstrated superior outcomes compared to the relaxation group, including better FIQ values after treatment (B = -3.01; p = 0.003). Differences in FIQ were maintained at 3-month follow-up (B = -3.33; p = 0.001). The absolute risk reduction in ABCT compared to relaxation increased by 40.0%, with an NNT = 3 based on criteria of =50% FIQ reduction after treatment. Psychological flexibility had a significant mediating effect on improvements. Conclusion: These results suggest that ABCT combined with TAU appears to be effective in the treatment of FM symptoms. Clinical Trial Registration: http://ClinicalTrials.gov, identifier NCT02454244.
000065586 536__ $$9info:eu-repo/grantAgreement/ES/ISCIII/RD12-0005-0001
000065586 540__ $$9info:eu-repo/semantics/openAccess$$aby$$uhttp://creativecommons.org/licenses/by/3.0/es/
000065586 590__ $$a3.161$$b2018
000065586 591__ $$aPSYCHIATRY$$b37 / 141 = 0.262$$c2018$$dQ2$$eT1
000065586 591__ $$aPSYCHIATRY$$b54 / 146 = 0.37$$c2018$$dQ2$$eT2
000065586 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion
000065586 700__ $$0(orcid)0000-0003-4842-0453$$aNavarro-Gil, M.$$uUniversidad de Zaragoza
000065586 700__ $$aPuebla-Guedea, M.
000065586 700__ $$aLuciano, J.V.
000065586 700__ $$aVan Gordon, W.
000065586 700__ $$aShonin, E.
000065586 700__ $$0(orcid)0000-0002-3797-4218$$aGarcía-Campayo, J.$$uUniversidad de Zaragoza
000065586 7102_ $$11007$$2745$$aUniversidad de Zaragoza$$bDpto. Medicina, Psiqu. y Derm.$$cArea Psiquiatría
000065586 7102_ $$14009$$2735$$aUniversidad de Zaragoza$$bDpto. Psicología y Sociología$$cÁrea Psicolog.Evolut.Educac
000065586 773__ $$g8 (2018), Art 304 [11 pp]$$tFrontiers in Psychiatry$$x1664-0640
000065586 8564_ $$s200636$$uhttp://zaguan.unizar.es/record/65586/files/texto_completo.pdf$$yVersión publicada
000065586 8564_ $$s100494$$uhttp://zaguan.unizar.es/record/65586/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada
000065586 909CO $$ooai:zaguan.unizar.es:65586$$particulos$$pdriver
000065586 951__ $$a2019-07-09-12:38:05
000065586 980__ $$aARTICLE